{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:00:50Z","timestamp":1766901650116,"version":"3.48.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10783-x","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:36:50Z","timestamp":1752237410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of HLA-DRA, HLA-DQA1, and IL-6 gene variations with susceptibility to multiple sclerosis"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-5652","authenticated-orcid":false,"given":"Gulsah","family":"Koc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-6778","authenticated-orcid":false,"given":"Aysegul","family":"Sahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2363-7568","authenticated-orcid":false,"given":"Busranur","family":"Oguz Selcuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-7101","authenticated-orcid":false,"given":"Fusun","family":"Mayda Domac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-5141","authenticated-orcid":false,"given":"Serkan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-0064","authenticated-orcid":false,"given":"Mesrure","family":"Koseoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0535-1364","authenticated-orcid":false,"given":"Ebru Hatun","family":"Uludasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-7344","authenticated-orcid":false,"given":"Deniz","family":"Kirac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"10422","key":"10783_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, Weinstock-Guttman B (2024) Multiple sclerosis. Lancet (London England) 403(10422):183\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(23)01473-3","journal-title":"Lancet (London England)"},{"issue":"1","key":"10783_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis - a review. Eur J Neurol 26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"issue":"14","key":"10783_CR3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler 26(14):1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"issue":"12 Suppl","key":"10783_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio A (2013) Environmental factors in multiple sclerosis. Expert Rev Neurother 13(12 Suppl):3\u20139. https:\/\/doi.org\/10.1586\/14737175.2013.865866","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10783_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/WCO.0000000000000319","volume":"29","author":"PP Axisa","year":"2016","unstructured":"Axisa PP, Hafler DA (2016) Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 29(3):345\u2013353. https:\/\/doi.org\/10.1097\/WCO.0000000000000319","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"10783_CR6","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1177\/1352458510376177","volume":"16","author":"M Shahbazi","year":"2010","unstructured":"Shahbazi M, Ebadi H, Fathi D et al (2010) HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Mult Scler 16(10):1173\u20131177. https:\/\/doi.org\/10.1177\/1352458510376177","journal-title":"Mult Scler"},{"key":"10783_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach JA, Oksenberg JR (2015) The immunogenetics of multiple sclerosis: A comprehensive review. J Autoimmun 64:13\u201325. https:\/\/doi.org\/10.1016\/j.jaut.2015.06.010","journal-title":"J Autoimmun"},{"doi-asserted-by":"publisher","unstructured":"De Silvestri A, Capittini C, Mallucci G, Bergamaschi R, Rebuffi C, Pasi A, Martinetti M, Tinelli C (2019) The The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis. Dis Markers 2019:1409069. https:\/\/doi.org\/10.1155\/2019\/1409069","key":"10783_CR8","DOI":"10.1155\/2019\/1409069"},{"issue":"7359","key":"10783_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S, International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2 (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214\u2013219. https:\/\/doi.org\/10.1038\/nature10251","journal-title":"Nature"},{"issue":"18","key":"10783_CR10","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.1073\/pnas.0812664106","volume":"106","author":"MR Lincoln","year":"2009","unstructured":"Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC (2009) Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 106(18):7542\u20137547. https:\/\/doi.org\/10.1073\/pnas.0812664106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10783_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa073493","volume":"357","author":"DA Hafler","year":"2007","unstructured":"Hafler DA, Compston A, Sawcer S et al (2007) International multiple sclerosis genetics consortium; risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357(9):851\u2013862. https:\/\/doi.org\/10.1056\/NEJMoa073493","journal-title":"N Engl J Med"},{"issue":"11","key":"10783_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/jclinpath-2014-202493","volume":"67","author":"P Ataie-Kachoie","year":"2014","unstructured":"Ataie-Kachoie P, Pourgholami MH, Richardson DR, Morris DL (2014) Gene of the month: Interleukin 6 (IL-6). J Clin Pathol 67(11):932\u2013937. https:\/\/doi.org\/10.1136\/jclinpath-2014-202493","journal-title":"J Clin Pathol"},{"issue":"12","key":"10783_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones SA, Jenkins BJ (2018) Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol 18(12):773\u2013789. https:\/\/doi.org\/10.1038\/s41577-018-0066-7","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10783_CR14","first-page":"1104","volume":"6","author":"Z Stelmasiak","year":"2000","unstructured":"Stelmasiak Z, Kozio\u0142-Montewka M, Dobosz B et al (2000) Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients. Med Sci Monit 6(6):1104\u20131108","journal-title":"Med Sci Monit"},{"key":"10783_CR15","doi-asserted-by":"publisher","first-page":"647588","DOI":"10.3389\/fimmu.2021.647588","volume":"15","author":"H Lu","year":"2021","unstructured":"Lu H, Wu PF, Zhang W, Liao X (2021) Circulating interleukins and risk of multiple sclerosis: A Mendelian randomization study. Front Immunol Apr 15:12:647588. https:\/\/doi.org\/10.3389\/fimmu.2021.647588","journal-title":"Front Immunol Apr"},{"issue":"5","key":"10783_CR16","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms25052589","volume":"25","author":"C Grunwald","year":"2024","unstructured":"Grunwald C, Kr\u0119towska-Grunwald A, Adamska-Patruno E, Kochanowicz J, Ku\u0142akowska A, Chor\u0105\u017cy M (2024) The role of selected interleukins in the development and progression of multiple Sclerosis-A systematic review. Int J Mol Sci 25(5):2589. https:\/\/doi.org\/10.3390\/ijms25052589","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10783_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/gtmb.2013.0387","volume":"18","author":"S Hu","year":"2014","unstructured":"Hu S, Chen Y, Sun XD, Li FJ, Shu QF, Liu XL, Jiang SF (2014) Association between IL-6-174G\/C polymorphism and risk of multiple sclerosis: a meta-analysis. Genet Test Mol Biomarkers 18(2):127\u2013130. https:\/\/doi.org\/10.1089\/gtmb.2013.0387","journal-title":"Genet Test Mol Biomarkers"},{"issue":"10","key":"10783_CR18","doi-asserted-by":"publisher","first-page":"13667","DOI":"10.3390\/ijms131013667","volume":"13","author":"J Yan","year":"2012","unstructured":"Yan J, Liu J, Lin CY et al (2012) Interleukin-6 gene promoter-572\u00a0C allele May play a role in rate of disease progression in multiple sclerosis. Int J Mol Sci 13(10):13667\u201313679. https:\/\/doi.org\/10.3390\/ijms131013667","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10783_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1399-0039.1972.tb00060.x","volume":"2","author":"J Bertrams","year":"1972","unstructured":"Bertrams J, Kuwert E, Liedtke U (1972) HLA antigens and multiple sclerosis. Tissue Antigens 2(5):405\u2013408. https:\/\/doi.org\/10.1111\/j.1399-0039.1972.tb00060.x","journal-title":"Tissue Antigens"},{"issue":"9","key":"10783_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.tig.2021.04.012","volume":"37","author":"R Martin","year":"2021","unstructured":"Martin R, Sospedra M, Eiermann T, Olsson T (2021) Multiple sclerosis: doubling down on MHC. Trends Genet 37(9):784\u2013797. https:\/\/doi.org\/10.1016\/j.tig.2021.04.012","journal-title":"Trends Genet"},{"issue":"7","key":"10783_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/jamaneurol.2016.0980","volume":"73","author":"N Isobe","year":"2016","unstructured":"Isobe N, Keshavan A, Gourraud PA et al (2016) Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis. JAMA Neurol 73(7):795\u2013802. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0980","journal-title":"JAMA Neurol"},{"issue":"9","key":"10783_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa073493","volume":"357","author":"DA Hafler","year":"2007","unstructured":"International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A et al (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357(9):851\u2013862. https:\/\/doi.org\/10.1056\/NEJMoa073493","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10783_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2012.10.014","volume":"255","author":"Y Bene\u0161ov\u00e1","year":"2013","unstructured":"Bene\u0161ov\u00e1 Y, Va\u0161k\u016f A, Stoura\u010d P, Hlad\u00edkov\u00e1 M, Fiala A, Bedna\u0159\u00edk J (2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J Neuroimmunol 255(1\u20132):92\u201396. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.014","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10783_CR24","doi-asserted-by":"publisher","first-page":"e11296","DOI":"10.1371\/journal.pone.0011296","volume":"5","author":"BA Cree","year":"2010","unstructured":"Cree BA, Rioux JD, McCauley JL et al (2010) A major histocompatibility class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS ONE 5(6):e11296. https:\/\/doi.org\/10.1371\/journal.pone.0011296","journal-title":"PLoS ONE"},{"issue":"12","key":"10783_CR25","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/cea.12000","volume":"42","author":"J Lasky-Su","year":"2012","unstructured":"Lasky-Su J, Himes BE, Raby BA et al (2012) HLA-DQ strikes again: genome-wide association study further confirms HLA-DQ in the diagnosis of asthma among adults. Clin Exp Allergy 42(12):1724\u20131733. https:\/\/doi.org\/10.1111\/cea.12000","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10783_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/CON.0000000000001136","volume":"28","author":"M Ward","year":"2022","unstructured":"Ward M, Goldman MD (2022) Epidemiology and pathophysiology of multiple sclerosis. Continuum 28(4):988\u20131005. https:\/\/doi.org\/10.1212\/CON.0000000000001136","journal-title":"Continuum"},{"issue":"2","key":"10783_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","volume":"141","author":"X Yao","year":"2014","unstructured":"Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y (2014) Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 141(2):125\u2013139. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.09.004","journal-title":"Pharmacol Ther"},{"issue":"1\u20132","key":"10783_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jneuroim.2006.03.004","volume":"175","author":"C Malmestr\u00f6m","year":"2006","unstructured":"Malmestr\u00f6m C, Andersson BA, Haghighi S, Lycke J (2006) IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles. J Neuroimmunol 175(1\u20132):176\u2013182. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.03.004","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10783_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.04.014","volume":"236","author":"D Mirowska-Guzel","year":"2011","unstructured":"Mirowska-Guzel D, Gromadzka G, Mach A, Czlonkowski A, Czlonkowska A (2011) Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-\u03b1 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol 236(1\u20132):87\u201392. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.04.014","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10783_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13760-018-0994-9","volume":"118","author":"Y Bene\u0161ov\u00e1","year":"2018","unstructured":"Bene\u0161ov\u00e1 Y, Va\u0161k\u016f A, Bienertov\u00e1-Va\u0161k\u016f J (2018) Association of Interleukin 6, Interleukin 7 receptor alpha, and Interleukin 12B gene polymorphisms with multiple sclerosis. Acta Neurol Belg 118(3):493\u2013501. https:\/\/doi.org\/10.1007\/s13760-018-0994-9","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10783_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s0198-8859(97)00086-4","volume":"55","author":"G Saruhan-Direskeneli","year":"1997","unstructured":"Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M (1997) HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol 55(1):59\u201365. https:\/\/doi.org\/10.1016\/s0198-8859(97)00086-4","journal-title":"Hum Immunol"},{"issue":"7","key":"10783_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.humimm.2004.05.004","volume":"65","author":"B D\u00f6nmez","year":"2004","unstructured":"D\u00f6nmez B, Ozakbas S, Oktem MA, Gedizlioglu M, Coker I, Genc A, Idiman E (2004) HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum Immunol 65(7):752\u2013757. https:\/\/doi.org\/10.1016\/j.humimm.2004.05.004","journal-title":"Hum Immunol"},{"doi-asserted-by":"publisher","unstructured":"Sahbaz A, Selcuk BO, Domac FM, Demir S, Koseoglu M, Uludasdemir EH, Koc G, Y\u0131lmaz B, Kirac D (2025) Effects of HLA-DRA, HLA-DQA1 and IL-6 gene variations to glatiramer acetate resistance in multiple sclerosis patients. Biochem genet 0.1007\/s10528-025-11077-4. https:\/\/doi.org\/10.1007\/s10528-025-11077-4. Advance online publication","key":"10783_CR33","DOI":"10.1007\/s10528-025-11077-4"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10783-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:25:48Z","timestamp":1766895948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10783-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10783"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10783-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures in this study involving human participants adhered to the ethical standards set by the institutional and\/or national research committees, in line with the 1964 Helsinki Declaration and its later amendments or equivalent ethical guidelines. Approval was granted by the local ethics committee (Istanbul Aydin University Ethical Committee, Ethics No: B.30.2.AYD.0.00.00-050.06.04\/43). All participants consented to take part in the study and signed an informed consent form before the study began.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In the study, all individuals who participated in the study signed the informed consent form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"701"}}